International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company operates as a licensed bank for personal storage of cord blood stem cells and tissue of the umbilical cord in Russia and the CIS countries. The company was founded in 2003 and is based in Moscow, Russia. International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company is a subsidiary of Human Stem Cells Institute PJSC.
Frequently asked questions
What sector does International Medical Center of Biomaterials Processing and Cryostorage (GEMA) operate in?
International Medical Center of Biomaterials Processing and Cryostorage belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is International Medical Center of Biomaterials Processing and Cryostorage (GEMA) current stock price?
As of the latest data, International Medical Center of Biomaterials Processing and Cryostorage stock price is RUB 89.50, with a previous close of RUB 89.50.
What is International Medical Center of Biomaterials Processing and Cryostorage (GEMA) current market capitalization?
International Medical Center of Biomaterials Processing and Cryostorage market cap is approximately 1.34 billion.
Does International Medical Center of Biomaterials Processing and Cryostorage (GEMA) pay dividends?
Yes. International Medical Center of Biomaterials Processing and Cryostorage pays other dividends with an annualized yield of 6.19% and an estimated annual payout of RUB 5.54 per share.
When is the next ex-dividend date for International Medical Center of Biomaterials Processing and Cryostorage (GEMA)?
The next ex-dividend date is scheduled for June 15, 2027.
What is International Medical Center of Biomaterials Processing and Cryostorage (GEMA) beta (volatility) score?
International Medical Center of Biomaterials Processing and Cryostorage has a beta of 0.629, indicating lower volatility than the overall market.
